LpxC inhibitor (KBP Biosciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLpxC inhibitor (KBP Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesKBP Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKBP Biosciences Co Ltd
Active IndicationsN/A
Inactive IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A